ProMed Insight - Page 2

Keratosis Pilaris: Rough Bumps and Smoothing Treatments

Keratosis Pilaris: Rough Bumps and Smoothing Treatments
Allison Wood Feb 7 2026

Keratosis pilaris causes rough, bumpy skin on arms and thighs-common, harmless, but frustrating. Learn what actually works: lactic acid, urea creams, and smart skincare routines to smooth skin without irritation.

Read More >>

Metformin for PCOS: How It Boosts Ovulation and Improves Insulin Sensitivity

Metformin for PCOS: How It Boosts Ovulation and Improves Insulin Sensitivity
Allison Wood Feb 7 2026

Metformin helps women with PCOS ovulate and improve insulin sensitivity, offering a low-cost, safe option for infertility and long-term metabolic health. Learn how it works, who benefits most, and how it compares to other treatments.

Read More >>

How DTC Advertising Shapes Patient Perceptions of Generic Medications

How DTC Advertising Shapes Patient Perceptions of Generic Medications
Allison Wood Feb 4 2026

Direct-to-consumer drug ads in the U.S. drive patients to request branded medications, even when generics are available. Research shows these ads increase overall drug use but often lead to inappropriate prescriptions. Learn how advertising affects choices between expensive brands and affordable generics.

Read More >>

Consequences of Not Taking Medications as Prescribed by Your Doctor

Consequences of Not Taking Medications as Prescribed by Your Doctor
Allison Wood Feb 3 2026

Skipping prescribed medication can lead to hospitalization, preventable death, and billions in avoidable healthcare costs. Learn why people miss doses and what actually helps them stay on track.

Read More >>

Fibromyalgia: Understanding Widespread Pain and the Role of Antidepressants

Fibromyalgia: Understanding Widespread Pain and the Role of Antidepressants
Allison Wood Feb 2 2026

Fibromyalgia causes widespread pain, fatigue, and sleep issues. Antidepressants like duloxetine and amitriptyline help by calming overactive pain signals - but exercise is the most effective long-term treatment. Learn how to manage symptoms with science-backed strategies.

Read More >>

Psychiatric Medication Combinations: Generic Alternatives and What You Need to Know

Psychiatric Medication Combinations: Generic Alternatives and What You Need to Know
Allison Wood Jan 31 2026

Psychiatric medication combinations can be life-changing-but switching to generics can break them. Learn why small differences in generic drugs can cause relapses, hospitalizations, and treatment failure, and what you can do to protect your mental health.

Read More >>

Long-term safety of generic vs brand drugs: what the data really shows

Long-term safety of generic vs brand drugs: what the data really shows
Allison Wood Jan 30 2026

Long-term studies show generics are often just as safe as brand drugs - but not always. Manufacturing origin, inactive ingredients, and individual sensitivity matter more than the brand label. Here’s what the data really says.

Read More >>

Liability and Indemnification in Generic Transactions: What You Need to Know

Liability and Indemnification in Generic Transactions: What You Need to Know
Allison Wood Jan 29 2026

Indemnification in commercial transactions shifts financial risk from one party to another. Learn how liability clauses work, what triggers payouts, and how to protect yourself in contracts.

Read More >>

How Government Controls Generic Drug Prices in the U.S. - What You Really Pay

How Government Controls Generic Drug Prices in the U.S. - What You Really Pay
Allison Wood Jan 27 2026

Government control of generic drug prices in the U.S. works through rebates, Medicare caps, and safety-net programs - not direct price setting. Here’s how it really affects what you pay at the pharmacy.

Read More >>

Prior Authorization: How Providers Secure Approval for Generic Medications

Prior Authorization: How Providers Secure Approval for Generic Medications
Allison Wood Jan 26 2026

Prior authorization for generic medications remains a major administrative burden for providers. Learn how doctors and clinics navigate insurance rules, submit documentation, and secure faster approvals for low-cost generics.

Read More >>

Effective Patent Life: Why Market Exclusivity for Drugs Is Shorter Than You Think

Effective Patent Life: Why Market Exclusivity for Drugs Is Shorter Than You Think
Allison Wood Jan 26 2026

Effective patent life for drugs is often just 10-15 years, not the full 20, because most of the patent term is used up during clinical trials and FDA review. Secondary patents and regulatory exclusivities extend this further, delaying generic competition.

Read More >>

Cerebral Aneurysm: Rupture Risk and Treatment Options

Cerebral Aneurysm: Rupture Risk and Treatment Options
Allison Wood Jan 24 2026

Cerebral aneurysms affect 3.2% of people, but most never rupture. Learn what makes them dangerous, how the PHASES score predicts risk, and the real differences between clipping, coiling, and flow diversion treatments.

Read More >>